NeoGenomics, Inc.
NASDAQNeoGenomics enters its April 29 Q1 earnings release with a notable divergence between a surging stock price and a short position that has been quietly growing all month. The price tells a recovery story: shares closed at $9.02 on April 28, up 25% over the past month and 13% on the week. Yet short interest has moved in the opposite direction. At 6.8% of the free float, the short…
Snapshot as of 9 May 2026
NeoGenomics enters its April 29 Q1 earnings release with a notable divergence between a surging stock price and a short position that has been quietly growing all month. The price tells a recovery story: shares closed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NEO — free to start on ORTEX.
Sign up for free →Open NEO on ORTEX